Autoimmune and Chronic Inflammatory Disease Patients with COVID-19.

ABSTRACT:

Objective

There are limited data on the impact of coronavirus disease 2019 (COVID-19) on hospitalized patients with autoimmune and chronic inflammatory disease (AICID) compared with patients who do not have AICID. We sought to evaluate whether patients with AICID who have confirmed COVID-19 presenting to the hospital are at higher risk of adverse outcomes compared with those patients without AICID who are infected with COVID-19 and whether immunosuppressive medications impact this risk.

Methods

We performed a multicenter retrospective cohort study with patients presenting to five hospitals in a large academic health system with polymerase chain reaction-confirmed COVID-19 infection. We evaluated the impact of having an AICID and class of immunosuppressive medication being us

SUBMITTER: Ungaro RC 

PROVIDER: S-EPMC7882518 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature